Also the last point in the Summary makes it pretty clear what they want to do;
• Transaction for entire company preferred as value event for shareholders, versus licensing or partnering
In other words once the trials have been complete and the ducks are lined up they will be selling it out to big pharma.
Ex AstraZeneca team working on re purposed formula for the company...one would assume they did the original Byetta formula.
Cant imagine why AstraZeneca wouldn't just add it to their production pipeline if everything worked out positive.
- Forums
- ASX - By Stock
- IXC
- Ann: Investor Presentation
Ann: Investor Presentation, page-6
-
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IXC (ASX) to my watchlist
|
|||||
Last
7.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.411M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 29320 | 7.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.2¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 29320 | 0.070 |
1 | 100000 | 0.066 |
1 | 100000 | 0.065 |
1 | 84879 | 0.063 |
2 | 158500 | 0.060 |
Price($) | Vol. | No. |
---|---|---|
0.072 | 10000 | 1 |
0.075 | 8695 | 1 |
0.080 | 5000 | 1 |
0.090 | 126146 | 1 |
0.095 | 100000 | 1 |
Last trade - 16.12pm 26/08/2024 (20 minute delay) ? |
Featured News
IXC (ASX) Chart |
Day chart unavailable